Monday, September 1, 2014

Portfolio Allocation - 8/31/14

Here is my month end (8/31/14) portfolio allocation.  All positions are long positions, and each is labeled to indicate calls or common stock.

KERX - 37.1% (calls)
ARIA - 16.7 (calls)
ALNY - 10.5 (common)
ARWR - 8.8 (common)
XLF - 7.4 (calls)
ISIS - 6.1 (common)
SGYP - 5.9 (common)
SPPI - 4.1 (calls)

Cash - 3.4

Tuesday, August 26, 2014

Biotech diversity

Recent gains in Keryx Biopharmaceuticals had skewed my portfolio wildly to that one holding (more than 70%).  So today I sold my existing long call position (which was to expire in January) in Keryx and reinvested about half the proceeds into longer dated (March 2015) Keryx calls at a higher strike price.  I put the other half of the proceeds into common stock of several names I've been watching for years, some of which I previously owned.  These are Alnylam Pharmaceuticals, Arrowhead Research, Isis Pharmaceuticals, and Synergy Pharmaceuticals.  These moves retain my exposure to biotech, but in a more diversified way, and with a bit more conservatism (common stock instead of calls).

Friday, August 1, 2014

Portfolio Allocation - 7/31/14

Here is my month end (7/31/14) portfolio allocation.  For simplicity, unless otherwise noted, all positions are long call option positions.

KERX - 61.8%
ARIA - 22.1
XLF - 8.1
SPPI - 5.5

Cash - 2.5

Tuesday, July 1, 2014

Portfolio Allocation - 6/30/14

Here is my month and quarter end (6/30/14) portfolio allocation.  For simplicity, unless otherwise noted, all positions are long call option positions.

KERX - 59.1%
ARIA - 24.0
XLF - 8.0
SPPI - 6.7

Cash - 2.2

Sunday, June 1, 2014

Portfolio Allocation - 5/31/14

Here is my month end (5/31/14) portfolio allocation.  For simplicity, unless otherwise noted, all positions are long call option positions.

KERX - 56.6%
ARIA - 27.1
XLF - 7.3
SPPI - 6.3

Cash - 2.7

Thursday, May 1, 2014

Portfolio Allocation - 4/30/14

Here is my month end (4/30/14) portfolio allocation.  For simplicity, unless otherwise noted, all positions are long call option positions.

KERX - 56.5%
ARIA - 32.1
XLF - 5.6
SPPI - 3.6

Cash - 2.2

Tuesday, April 1, 2014

Portfolio Allocation - 3/31/14

Here is my month and quarter end (3/31/14) portfolio allocation.  For simplicity, unless otherwise noted, all positions are long call option positions.

KERX - 57.4%
ARIA - 30.9
XLF - 5.2
SPPI - 4.8

Cash - 1.7

Monday, March 3, 2014

Portfolio Allocation - 2/28/14

Here is my month end (2/28/14) portfolio allocation.  For simplicity, unless otherwise noted, all positions are long call option positions.

KERX - 53.4%
ARIA - 34.8
SPPI - 6.3
XLF - 3.9

Cash - 1.5

Sunday, February 2, 2014

Portfolio Allocation - 1/31/14

Here is my month end (1/31/14) portfolio allocation.  For simplicity, unless otherwise noted, all positions are long call option positions.

KERX - 55.5%
ARIA - 31.1
SPPI - 7.6
XLF - 3.9

Cash - 1.9

Tuesday, January 14, 2014

Some trades before expiration

A few of my call option positions are going to expire at the end of the week, and two of those three will almost certainly expire worthless.  But I needed to trade the one that still had value, so I did that today.  Specifically, I pushed my position in the Financial Select Sector SPDR from Jan 2014 to Jan 2015 (and doubled it's modest allocation in the process).  I also added to existing positions in Ariad Pharmaceuticals and Spectrum Pharmaceuticals, although at different strike prices than my previous calls.  I funded these moves by selling one quarter of my position in Keryx Biopharmaceuticals.  Keryx is now a bit less than 50% of my portfolio, which is still higher than I would prefer, given their risk profile.  But at least the portfolio now has better balance than the past few months.  And all remaining positions of value don't expire for a full year, leaving plenty of time for these stories to play out in 2014.